| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 1.71M | £ 5.05M | £ 4.57M | £ 2.40M | £ 1.16M |
| Gross Profit | £ 1.05M | £ 1.54M | £ 4.57M | £ 2.40M | £ 1.16M |
| Operating Income | £ -4.67M | £ -10.70M | £ -9.18M | £ -11.66M | £ -5.98M |
| EBITDA | £ -4.45M | £ -10.15M | £ -8.39M | £ -10.06M | £ -6.27M |
| Net Income | £ 664.00K | £ -10.24M | £ -8.55M | £ -9.26M | £ -6.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 6.13M | £ 3.26M | £ 6.75M | £ 12.81M | £ 18.32M |
| Total Assets | £ 8.10M | £ 8.72M | £ 15.38M | £ 21.77M | £ 20.92M |
| Total Debt | £ 98.00K | £ 232.00K | £ 338.00K | £ 288.00K | £ 231.00K |
| Net Debt | £ -2.90M | £ -3.01M | £ -4.75M | £ -4.48M | £ -18.09M |
| Total Liabilities | £ 1.65M | £ 3.37M | £ 5.85M | £ 4.31M | £ 2.37M |
| Stockholders' Equity | £ 6.45M | £ 5.35M | £ 9.53M | £ 17.45M | £ 18.55M |
| Cash Flow | |||||
| Free Cash Flow | £ -2.39M | £ -9.18M | £ -5.99M | £ -11.13M | £ -5.52M |
| Operating Cash Flow | £ -2.29M | £ -9.15M | £ -5.84M | £ -10.78M | £ -5.45M |
| Investing Cash Flow | £ 2.38M | £ 1.72M | £ 6.52M | £ -7.99M | £ -68.00K |
| Financing Cash Flow | £ -148.00K | £ 5.65M | £ -180.00K | £ 5.16M | £ 20.93M |
Arecor Therapeutics PLC (DE:6UI)
FRANKFURT:6UI
